Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Alpha Healthcare Acquisition Corporation III | ALPAU | NASDAQ | Trust |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 9.75 | 18:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 9.75 | 9.75 |
| Trades | Shares Traded | Average Volume |
|---|---|---|
| 0 | 0 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | 9.75 | USD |
Alpha Healthcare Acquisition Corporation III Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 225.05M | 23.08M | - | 0 | -16.12M | -0.70 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Alpha Healthcare Acquisi...
| Date | Time | Source | Heading |
|---|---|---|---|
| 8/30/2024 | 15:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 8/30/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/30/2024 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 8/30/2024 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 8/30/2024 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 8/16/2024 | 08:27 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 8/14/2024 | 15:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 7/29/2024 | 07:39 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 7/29/2024 | 07:38 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/17/2024 | 16:19 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/30/2024 | 09:36 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 4/29/2024 | 16:08 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
ALPAU Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Carmell Corporation (CTCX) is a bio-aesthetics company that utilizes the Carmell SecretomeTM to support skin and hair health. The Carmell SecretomeTM consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from U.S. Food and Drug Administration-approved tissue banks. Over the past seven years, Carmell has extensively tested the technology underpinning the Carmell SecretomeTM. In addition, Carmell has developed a novel microemulsion formulation that enables the delivery of lipophilic and hydrophilic ingredients without relying on the Foul FourteenTM, which are 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell's microemulsion formulations do not utilize mineral or vegetable oils across its entire product line and are designed to be non-comedogenic. |
NASDAQ:ALPAU -
What is the current Alpha Healthcare Acquisition Corporation III share price?
The current share price of Alpha Healthcare Acquisition Corporation III is US$ 9.75
How many Alpha Healthcare Acquisition Corporation III shares are in issue?
Alpha Healthcare Acquisition Corporation III has 23,082,000 shares in issue
What is the market cap of Alpha Healthcare Acquisition Corporation III?
The market capitalisation of Alpha Healthcare Acquisition Corporation III is USD 225.05M
What is the 1 year trading range for Alpha Healthcare Acquisition Corporation III share price?
Alpha Healthcare Acquisition Corporation III has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Alpha Healthcare Acquisition Corporation III?
The price to earnings ratio of Alpha Healthcare Acquisition Corporation III is -0.43
What is the reporting currency for Alpha Healthcare Acquisition Corporation III?
Alpha Healthcare Acquisition Corporation III reports financial results in USD
What is the latest annual profit for Alpha Healthcare Acquisition Corporation III?
The latest annual profit of Alpha Healthcare Acquisition Corporation III is USD -16.12M
What is the registered address of Alpha Healthcare Acquisition Corporation III?
The registered address for Alpha Healthcare Acquisition Corporation III is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Alpha Healthcare Acquisition Corporation III website address?
The website address for Alpha Healthcare Acquisition Corporation III is www.carmellrx.com
Which industry sector does Alpha Healthcare Acquisition Corporation III operate in?
Alpha Healthcare Acquisition Corporation III operates in the SURGICAL,MED INSTR,APPARATUS sector
